Table 1.
Immunization paradigm and group assignment
Group | Mice | Immunogen | Number of mice | Route | Adjuvant |
---|---|---|---|---|---|
1 | Littermate | Wt-Tau | 4 | Subcutaneous | Quil A |
2 | rTg4510 | Wt-Tau | 4 | Subcutaneous | Quil A |
3 | Littermate | P310L-Tau | 4 | Subcutaneous | Quil A |
4 | rTg4510 | P310L-Tau | 4 | Subcutaneous | Quil A |
5 | Littermate | PBS | 4 | Subcutaneous | Quil A |
6 | rTg4510 | PBS | 4 | Subcutaneous | Quil A |
rTg4510 mice (n = 12) and non-transgenic littermates (n = 12) were separated into 6 groups (n = 4 per group). Each mouse was subcutaneously injected with a mix solution of 1.1 mg/ml of each protein formulated in 2.0 mg/ml Quil A adjuvant. Each groups respective immunogen, immunization route, and adjuvant used are indicated. PBS, phosphate-buffered saline; Wt, wild-type.